MB&T
Loading...
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen shares top $100 as fears fade over biosimilars

By   /   Friday, April 5th, 2013  /   Comments Off on Amgen shares top $100 as fears fade over biosimilars

    Print       Email

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

George Savic of Analytical Ventura prepares pipe samples in his incubator space at the Ventura BioCenter.

Ventura BioCenter provides facilities, equipment for startups

Read More →